FORMULARY DECISION
Tocilizumab : RoActemra
1201/16 : Treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.
We have found 13 results when searching "Tocilizumab"
1201/16 : Treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.
SMC2014 : For the treatment of Giant Cell Arteritis (GCA) in adult patients.
SMC2552 : Treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. Refer to local guidelines